Health In Tech, Inc. (HIT) Fair Value 2026

HIT · Insurance Agents, Brokers & Service ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.4 /10

32 fundamental signals · 12 models active

Value Trap Risk

SAFE (6/100)

Quick Summary — As of 2026-07-13, Health In Tech, Inc. (HIT) trades at $1.06, approximately 40% above CirclFi’s Bayesian DCF fair value of $0.76. QOC: 8.4/10. Value Trap Risk: 6/100 (SAFE). 12/13 models active.

Key Facts

Ticker
HIT
Price
$1.06
Quality Score
8.4/10
Value Trap Risk
6/100
Models Active
12/13
Last Updated
Strength: Quality Score of 8.4/10 indicates strong fundamentals
Risk: Majority of models suggest overvaluation

Valuation Matrix

12 Intrinsic Value Models vs. Current Price ($1.06)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$0.76 -28.5%
Earnings Power Value
Medium Conviction
$0.09 -91.9%
CUCE Ensemble
Low Conviction
$0.50 -53.1%
First Chicago
Medium Conviction
$0.46 -56.2%

Unlock the Full Matrix

Access 8 additional models including EROIC Spread, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 12 Models →

Cancel anytime · No contracts · Instant access

What Is Health In Tech, Inc. (HIT) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Health In Tech, Inc.'s intrinsic value is estimated at $0.50, suggesting the stock is overvalued at its current price of $1.06. With 11 out of 12 models flagging downside (-52.5% average return), the market may be pricing in unsustainable growth. Notably, PWERM sees the most upside at +0.5% (fair value: $1.06), while EPV is the most conservative at -91.9% ($0.09). The spread between these extremes — +92.4% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About HIT?

12 of 13 models are currently active for HIT. Of these, 1 model suggests upside while 11 models suggest overvaluation. The Bayesian DCF estimates HIT's intrinsic value at $0.76, implying -28.5% downside from the current price. See which stocks rank higher →

How Does HIT Rank in Insurance Agents, Brokers & Service?

Among 24 Insurance Agents, Brokers & Service stocks, HIT ranks #9 by Quality of Company score. CirclFi's QOC score of 8.4/10 evaluates 32 fundamental signals. A score of 8.4 places HIT in the top tier.

Within the Insurance Agents, Brokers & Service space, Health In Tech, Inc. competes in an environment where premium growth rate often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is HIT a Value Trap?

CirclFi's Value Trap algorithm assigns HIT a score of 6/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

12 of 13 models are active for Health In Tech, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Health In Tech, Inc.'s fundamental quality profile registers 8.4/10. This robust score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +92.4% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every HIT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across HIT's 12 active models, average confidence is 37%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Health In Tech, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Insurance Agents, Brokers & Service Stocks Should You Also Analyze?

8 related Insurance Agents, Brokers & Service stocks with 13-model coverage

Read investment analysis: CRVL · HGTY · ERIE · MRSH · BRO

Frequently Asked Questions About Health In Tech, Inc.

What is Health In Tech, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Health In Tech, Inc. (HIT) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $0.76. The Quality of Company score is 8.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is HIT overvalued or undervalued right now?

At $1.06, 1 of 12 active models suggest HIT may be undervalued, while 11 indicate potential overvaluation. The assessment depends on which methodology best fits Health In Tech, Inc.'s business model in Insurance Agents, Brokers & Service.

What does a Quality of Company score of 8.4 mean for HIT?

Health In Tech, Inc.'s QOC of 8.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on HIT?

CirclFi analyzes HIT with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 12 of 13 are active for this stock. Read the full methodology →

Is HIT a value trap in 2026?

Health In Tech, Inc.'s Value Trap score is 6/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 12 mathematical frameworks give you clarity on HIT.

Unlock All 12 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access